Enokizumab Antibody
Enokizumab (MEDI-528) is a humanized monoclonal antibody targeting interleukin-9 (IL-9) . It serves as a key research tool for investigating the role of IL-9 in asthma pathogenesis, utilized in both in vitro cellular assays and in vivo preclinical models of allergic airway disease.
Product Specifications
Product Name Alternative
IL-9, ILReceptor, IL Receptor, MEDI 528, MEDI528, MEDI-528, Enokizumab
Target
Interleukin, IL Receptor
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
3.69 mg/mL
Purity
99.23% (May vary between batches)
Molecular Weight
145.98 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog